Nelson Sun

CIK: 0002045377

Transaction Breakdown

Open Market Buys (P)3 (37.5%)

High conviction signal

Open Market Sales (S)2 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AARD

Aardvark Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

AARD
Aardvark Therapeutics, Inc.
Sep 11, 2026
Sale(S)
Direct
62K shares at avg. $5.18$321K
AARD
Aardvark Therapeutics, Inc.
Sep 10, 2026
Sale(S)
Direct
14.8K shares at avg. $5.00$74K
AARD
Aardvark Therapeutics, Inc.
Feb 9, 2026
Award(A)
Stock option (right to buy)
Direct
70.5K shares-
AARD
Aardvark Therapeutics, Inc.
Dec 11, 2025
Purchase(P)
Direct
3K shares at avg. $14.40$43K
AARD
Aardvark Therapeutics, Inc.
Sep 9, 2025
Purchase(P)
Direct
6K shares at avg. $8.07$48K
AARD
Aardvark Therapeutics, Inc.
Jun 11, 2025
Award(A)
Stock Option (right to buy)
Direct
209.8K shares-
AARD
Aardvark Therapeutics, Inc.
Feb 14, 2025
Purchase(P)
Direct
10K shares at avg. $16.00$160K
AARD
Aardvark Therapeutics, Inc.
Feb 14, 2025
Conversion(C)
Direct
7K shares-

		Type	Shares	Price		Ownership
Sep 11, 2026	AARD Aardvark Therapeutics, Inc.	Sale(S)	62,000	$5.18	$321,179	Direct
Sep 10, 2026	AARD Aardvark Therapeutics, Inc.	Sale(S)	14,754	$5.00	$73,779	Direct
Feb 9, 2026	AARD Aardvark Therapeutics, Inc.	Award(A) Stock option (right to buy)	70,549	-	-	Direct
Dec 11, 2025	AARD Aardvark Therapeutics, Inc.	Purchase(P)	3,000	$14.40	$43,200	Direct
Sep 9, 2025	AARD Aardvark Therapeutics, Inc.	Purchase(P)	6,000	$8.07	$48,440	Direct
Jun 11, 2025	AARD Aardvark Therapeutics, Inc.	Award(A) Stock Option (right to buy)	209,826	-	-	Direct
Feb 14, 2025	AARD Aardvark Therapeutics, Inc.	Purchase(P)	10,000	$16.00	$160,000	Direct
Feb 14, 2025	AARD Aardvark Therapeutics, Inc.	Conversion(C)	7,001	-	-	Direct

1-8 of 8 transactions

About Sun Nelson

Sun Nelson (SEC CIK 0002045377) files insider reports with the SEC as Officer of Aardvark Therapeutics, Inc. (AARD).

Signal8 holds 7 ownership filings by Sun Nelson (1 Form 3, 6 Form 4), filed between Feb 12, 2025 and Sep 11, 2026. Those filings report 8 transactions, from Feb 14, 2025 to Sep 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sun Nelson's filings is in SAN DIEGO, CA.

Recent filings by Sun Nelson

Sep 11, 2026: Open-market sale of AARD shares (Form 4, code S).
Sep 10, 2026: Open-market sale of AARD shares (Form 4, code S).
Feb 9, 2026: Grant or award of AARD derivative securities (Form 4, code A).
Dec 11, 2025: Open-market purchase of AARD shares (Form 4, code P).
Sep 9, 2025: Open-market purchase of AARD shares (Form 4, code P).

Other insiders filing for Aardvark Therapeutics, Inc. (AARD)

Zhang Zhongwei, Director
Chi Jeffrey, Director
Graf Susan E, Director
Baynes Roy D., Director
Tong Victor Edward Jr, Director
Jaiman Manasi, Chief Medical Officer

How to read Form 4 transaction codes